Imunon, Inc. Prepaid Expense and Other Assets, Current
Imunon, Inc. (IMNN) had Prepaid Expense and Other Assets, Current of $115.22 thousand as of 2016-12-31, per its 10-K filed 2017-03-24.
Discontinued › Notes › and Other Assets
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2017-03-24
- 2016-12-31: Prepaid Expense and Other Assets, Current $115.22K.
- 2015-12-31: Prepaid Expense and Other Assets, Current $100.37K.
- 2014-12-31: Prepaid Expense and Other Assets, Current $235.13K.
- 2013-12-31: Prepaid Expense and Other Assets, Current $563.55K; Prepaid Expense and Other Assets, Current as first filed $401.79K.
| Period end | Prepaid Expense and Other Assets, Current | Prepaid Expense and Other Assets, Current as first filed |
|---|---|---|
| 2016-12-31 | $115.22K 10-K · filed 2017-03-24 | |
| 2015-12-31 | $100.37K 10-K · filed 2017-03-24 | |
| 2014-12-31 | $235.13K 10-K · filed 2016-03-30 | |
| 2013-12-31 | $563.55K 10-K · filed 2015-03-12 | $401.79K 10-K · filed 2014-03-13 |
| 2013-09-30 | $519.38K 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $520.73K 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $430.45K 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $190.73K 10-K · filed 2014-03-13 | $307.70K 10-Q · filed 2013-05-09 |
| 2012-09-30 | $103.73K 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $939.16K 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $1.18M 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $203.43K 10-Q · filed 2012-11-09 | $961.73K 10-K · filed 2012-03-15 |
| 2011-09-30 | $804.62K 10-Q · filed 2011-11-10 | |
| 2011-06-30 | $693.44K 10-Q · filed 2011-08-09 | |
| 2010-12-31 | $492.18K 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |